All posts by imreal

Global Pharma Experts to Spotlight Digital Transformation at the 2022…


The International Society for Pharmaceutical Engineering (ISPE) announced its 2022 ISPE Annual Meeting & Expo, taking place in Orlando, FL and virtually on 30 October–2 November. The conference…

(PRWeb August 18, 2022)

Read the full story at https://www.prweb.com/releases/global_pharma_experts_to_spotlight_digital_transformation_at_the_2022_ispe_annual_meeting_expo/prweb18849944.htm

MedTech Momentum Announces Acquisition of Wax Marketing


MedTech Momentum Welcomes Bonnie Harris to the team as VP of Strategy

Together we can provide unparalleled marketing services for the healthcare industry that combine the latest advancements in integrated marketing communications strategies with a powerful, proven marketing delivery engine.

MedTech Momentum, a leading healthcare marketing agency, is excited to announce the acquisition of Wax Marketing, a St. Paul, Minnesota based agency known for providing leading-edge marketing communications services for high-growth healthcare and technology clients. Wax Marketing founder Bonnie Harris will join MedTech Momentum in the role of Vice President of Strategy, assuming responsibility for managing and overseeing strategic initiatives for MedTech Momentum and its customers.

“Our challenge at MedTech Momentum is to continually raise the bar in terms of the breadth and depth of services we provide our customers worldwide. Bonnie Harris is a heavy hitter known for creating successful high growth roadmaps for healthcare technology firms. This investment will significantly deepen our capabilities in terms of strategic marketing communications services,” said Guillaume Viallaneix, MedTech Momentum founder and President.

MedTech Momentum was launched in 2014 by Medical Industry executives with decades of experience, to provide a home to MedTech Companies looking to partner with a marketing agency that spoke their language. 8 years later, MedTech Momentum’s team of 28 healthcare marketing experts has helped over 130 medical technology and healthcare technology organizations create marketing strategies and programs to help them achieve their growth goals. The company is on a mission to expand the depth and breadth of their services for existing and new clients, as well as providing additional thought leadership and guidance industry-wide.

“Prior to the acquisition, MedTech Momentum had engaged Wax Marketing as a consulting partner on several major initiatives. It was clear from the beginning that our services and our value systems were aligned,” said Bonnie Harris, founder of Wax Marketing. “Together we can provide unparalleled marketing services for the healthcare industry that combine the latest advancements in integrated marketing communications strategies with a powerful, proven marketing delivery engine.”

Bonnie Harris is an industry veteran with more than two decades of experience providing integrated marketing communications services within the healthcare, technology, and nonprofit industries. Prior to founding Wax Marketing, she led a successful technology startup, eventually overseeing several West Coast and Midwest branches of a large publicly-held IT services firm. The terms of the agreement were undisclosed.

For more information on this acquisition and how MedTech Momentum creates marketing that saves lives, visit MedTechMomentum.com.

About MedTech Momentum

Launched in 2014 MedTech Momentum is an experienced full-service healthcare marketing agency headquartered in the greater Orlando, Florida, area. Applying its signature “MT-7 Framework for Growth” formula, the company is 100% focused on helping healthcare organizations in the US and internationally execute sustainable and scalable value-driven growth strategies. Armed with a team of 28 renowned strategic advisors and creative personalities, MedTech Momentum possesses a unique vantage point on market dynamics and new technologies in the digital era.

Share article on social media or email:

New Study Shows BONESUPPORT’s CERAMENT G Technology Delivers 94% Limb Salvage Rate for Patients with Diabetic Foot Infections


News Image

The clinical study published by Vasukutty et al. is powerful validation of our groundbreaking technology for the management of diabetic bone infection, especially in a challenging cohort of patients.

BONESUPPORT, an emerging leader in orthobiologics, announced CERAMENT G is the focus of a new study highlighting the impact of the technology in the management of patients with diabetic foot infection. As the first injectable combination antibiotic bone graft substitute, CERAMENT G can be used in a single-stage procedure to simultaneously support bone remodeling and locally elute Gentamicin (antibiotic) to protect bone healing. The series, recently published in The Diabetic Foot Journal, shows that the use of CERAMENT G which elutes local antibiotic, along with a surgical debridement, can achieve infection clearance close to 90% and limb salvage rates 94%..

“The clinical study published by Vasukutty et al. is powerful validation of our groundbreaking technology for the management of diabetic bone infection, especially in a challenging cohort of patients,” said Michael Diefenbeck, EVP of Medical & Clinical Affairs and Chief Medical Officer at BONESUPPORT. “The result of this protocol demonstrating significant limb salvage success, is an improved quality of life for patients and an improved outcome for surgeons. We know this is just the beginning of the impact of our technology for supporting the treatment of bone infections.”

Diabetic foot infection is associated with high morbidity and is one of the leading causes of lower limb amputation. It can often be irreversibly debilitating, is susceptible to infection recurrence, and can lead to limb amputations. The authors of the new study presented results of 47 patients from two centers in the UK. Their multidisciplinary protocol involved pre-operative assessment, debridement, culture-specific systemic antibiotics, and local antimicrobial management with an antibiotic eluting biocomposite from BONESUPPORT. Researchers noted that “this is a safe procedure with no local or systemic adverse effects.”

BONESUPPORT received market authorization from the U.S. Food and Drug Administration (FDA), for CERAMENT G, for the indication of bone infection (osteomyelitis) in May. For more information about the study, visit Diabetic Foot Journal – and for a deeper dive into BONESUPPORT’S CERAMENT G technology that delivers proven bone remodeling with reliable and local elution of a broad-spectrum antibiotic, visit https://www.bonesupport.com/.

About BONESUPPORT

BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver. The company is based in Lund, Sweden, and the net sales amounted to SEK 213 million in 2021. Please visit http://www.bonesupport.com for more information.

BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.

Share article on social media or email:

A Quick Guideline On Getting Apple Products Repaired From a Repaired Store


Apple products have been trending in the market for quite a while now. These products have left the benchmark for themselves because of their extraordinary performance and ease of use. The products come with a highly interactive interface, making it easy for people to carry out all their operations with complete ease.

Another great thing about Apple products is their durability. The products may last for a prolonged span of time without requiring frequent repair and maintenance. However, Apple products can also malfunction at times because of various issues. Sometimes, the LCD screen of the device may get cracked because of any external force.

Sometimes, even the motherboard of the device may stop functioning properly. In that case, getting the product repaired is a good idea instead of buying a new one. It is not only going to be cost-effective but will also help in the reduction of E-waste generation.

Following are the steps to get your MacBook device repaired:

Checking The Warranty Of The Device:

If the laptop stops functioning, the device owner should first check the product’s warranty. If the product is within the warranty period, it must be taken to an Apple store. The authorities at the store can then get the product repaired or replaced completely free of cost. This can be the best way to get the device repaired.

However, if the warranty is over, then it is the responsibility of the owner to get their product repaired. In that case, it is important to go for a reputed only that would provide the best possible services at an affordable price range. Users can also get Macbook Air Logic Board I5 Online in Usa.

Identifying The Defect With The Product:

Once the Apple product is taken for repair to an unauthorized store, the store professionals will quickly analyze the product. They will ask the users about the exact issue they are facing, and depending on that, they will perform their checks. This will help them understand the problem’s actual cause so they can come up with a proper solution to resolve the issue.

The Apple device repair service provider will list all their findings and communicate that with the device’s owner. They will also provide the owner with an estimate of the cost and time required to complete the things perfectly. If the owner agrees, the service provided will start their work on the device. They will make sure that the required parts are repaired or replaced.

The professionals at the service center will only get the parts replaced if it is beyond repair. Otherwise, they will carry out repairing activities so that the laptop performs well again. However, it is important to go to a reputed service provider only so that Apple users get nothing but genuine parts for the device.

Getting To Know The Repairing Costs:

The cost of repair or replacement will completely depend on the extent of damage that was caused to the device. Also, the repairing cost is generally less than the replacement cost as no new parts are required in the process. The exact cost for repair can only be known after the exact problem with the device has been identified.

The service provider will provide the estimated cost before they start off with the repairing activity. In this way, the user will have an idea of how much they are supposed to pay and they will not land up in a state of shock at the end of the process.

Visiting a Reputed Store:

It is important for the Apple owner to take their device for repair to a reputed store only. Only then can they expect the best possible service. The reputation of the store can be checked by going through the ratings and reviews online. The users can also check the range of available services from the website. The affordability should also be a concern as no one loves to pay a huge amount of money on repairing their belongings.

So, for Macbook Air Logic Board I3 Online in Usa, it is important for the users to make the purchase from a reputable store only.

Share article on social media or email:

Baltimore Based Chiropractic and Physical Therapy Group Announces Two New Locations


“These will be a fantastic locations for us. We’re looking forward to being able to host opening events for our team and partners at an appropriate and safe future date. We’re always looking to expand our reach and are currently working on additional sites around the State of Maryland.”

Mid-Atlantic Spinal Rehab & Chiropractic, a leading Chiropractic and Physical Therapy practice, today announced two new office locations in the Baltimore, Maryland area. The new locations; 5670 The Alameda, Suite A, Baltimore, MD 21239, and 3401 Erdman Avenue, Suite A, Baltimore, MD 21213 will add to the company’s Baltimore area clinics. Mid Atlantic Spinal Rehab & Chiropractic now has 9 Baltimore, Maryland area locations and continues to add to their growing team of healthcare professionals.

According to CEO, Dr. Marc Gulitz, the expansion has been planned for some time. “Our vision has always been to serve all of Central Maryland, and then expand throughout the State and Region. We are excited about adding the two locations which create better access across Baltimore communities, along with our referring Doctors and partners. We’re also committed to expanding our team and creating healthcare jobs throughout Maryland.”

Mid-Atlantic Spinal Rehab specializes in the care of acute injuries caused by automobile or work related accidents. Adding these new locations is a strategic move that expands access to care for residents of Baltimore City. By expanding patient care access points Mid Atlantic plans to reach tens of thousands more Maryland residents.

“Given the number of residents, and referring partners in the Baltimore Metro Area, and the surrounding communities,” says Dr. Gulitz, “we expect these new locations to quickly grow in patient visits, and staff.”

About Mid-Atlantic Spinal Rehab & Chiropractic

Mid-Atlantic Spinal Rehab & Chiropractic specializes in the rehabilitation of acute musculoskeletal injuries, such as those commonly experienced in auto accidents and work related injuries. Our healthcare providers work alongside primary care physicians, pain management physicians, physical therapists, orthopedists, and neurologists to manage care, and provide positive outcomes for patients. Founded in 2012, Mid-Atlantic Spinal Rehab & Chiropractic is one of the fastest growing practices in the Region. For more information visit the website at http://www.midatlanticspinalrehab.com

About Growth Solutions Team

The Growth Solutions Team is a leading provider of Business Consulting, Sales & Customer Service Training, and Small Business Advisory services. Our team assists companies with revenue generation, profit maximization, business processes, Strategic HR, and business development. Our programs are designed to meet you where you are, and to generate lasting results for your company. For more information visit the website at https://growthsolutionsteam.com

Share article on social media or email:

Congestive Heart Failure Patients May Be Eligible for Treatment that Could Help Them Live Longer


Dr. Jonathan Roberts is medical director of Clinical Research and Education, Interventional Cardiology for Memorial Healthcare System and program director of its Cardiology Fellowship program.

“The exciting part to the patient participating in the TAVR trial at Memroial Cardiac and Vascular Institute is potentially having access to a treatment that otherwise wouldn’t be available to them.” – Jonathan Roberts, MD, FACC, FSCAI

Patients diagnosed with moderate aortic stenosis and congestive heart failure may qualify to participate in a clinical trial that will determine whether a minimally-invasive valve replacement benefits those who are currently treated only with medication.

The procedure, known by the acronym “TAVR” (Transcatheter Aortic Valve Replacement), is currently only approved for use in patients with severe aortic stenosis. In those cases, the aortic valve is replaced through a transcatheter process that replaces open-heart surgery and has resulted in individuals feeling better, avoiding hospital stays, and living longer.

To date, TAVR hasn’t been approved as an option for those with moderate aortic stenosis. Those patients currently receive medical therapy and are observed on guideline directed medical treatment until their condition worsens. The national ‘TAVR UNLOAD’ trial Memorial Cardiac and Vascular Institute is participating in seeks to determine whether performing the valve replacement much earlier, before the patient’s condition becomes severe, delivers the same benefits.

“The exciting part to the patient participating in the TAVR trial is potentially having access to a treatment that otherwise wouldn’t be available to them,” said Dr. Jonathan Roberts, medical director of Clinical Research and Education, Interventional Cardiology for Memorial Healthcare System and program director of its Cardiology Fellowship program. “TAVR is an amazing procedure that we perform quite frequently, but it’s new for us to be doing this on those whose disease hasn’t progressed to its later stages.”

The clinical trial will randomize patients with moderate aortic stenosis, with 50% of them receiving the TAVR procedure and the other half continuing with traditional medical therapy. Researchers expect the five-year comparison study to produce results that demonstrate whether those who have the procedure earlier get the same benefit as those who undergo TAVR once their heart disease becomes more severe and how those results compare with those who continued with guideline directed medical therapy. “Memorial’s participation in the trial is a direct result of the healthcare system’s ascension as an academic medical center with the expertise and patient volumes required of host facilities,” said Dr. Roberts.

Those who have been diagnosed with congestive heart failure and moderate aortic stenosis may be eligible to participate in the TAVR UNLOAD trial, which is currently accepting candidates that meet specific medical criteria. To learn more about eligibility, contact Memorial’s Office of Human Research at 954-265-1847.

# # #

The Memorial Cardiac & Vascular Institute is a cardiovascular care leader, offering a wide array of services dedicated to the prevention, detection, and treatment of cardiovascular disease. Its multi-disciplinary specialists collaborate using sophisticated diagnostic equipment and facilities. Cardiovascular care outcomes are regularly reviewed by physician-review panels and nurses to ensure quality assurance that utilizes computerized data collection.

For more information on total heart care, you can visit them at mhs.net/services/cardiac-vascular.

Share article on social media or email:

Liquid Biopsy in Oncology: Opportunities and Challenges, Upcoming…


In this free webinar, learn about the current methodologies involved in liquid biopsies and their application for detection of genetic mutations. Attendees will learn how liquid biopsies may help with…

(PRWeb August 18, 2022)

Read the full story at https://www.prweb.com/releases/liquid_biopsy_in_oncology_opportunities_and_challenges_upcoming_webinar_hosted_by_xtalks/prweb18849614.htm

The Christ Hospital Health Network Simplifies Breast Cancer Surgery With MOLLI


News Image

The Christ Hospital Health Network, known for providing the best, most compassionate care for its community, is the first in Ohio to adopt MOLLI Surgical’s wire-free and radiation-free breast cancer localization technology: MOLLI®. The MOLLI device features the smallest localization marker on the market that precisely marks where tumors are located prior to breast cancer surgery, helping the surgeon remove them more efficiently and improving the patient’s overall experience.

The Christ Hospital Health Network’s adoption of this technology reflects its commitment to doing everything it takes for patients, such as driving innovations like wire-free localization that improve the patient experience. Going forward, MOLLI Surgical will be the provider of wire-free, radiation-free technology for breast surgery.

“Marking the tumor for those needing breast cancer surgery can be a difficult experience for the patient — typically using a wire on the same day of surgery. MOLLI decouples localization from surgery, providing more flexibility for the patient,” says Jennifer B. Manders, MD. “Plus, the device is easy-to-use, efficient, and extremely precise. We chose MOLLI after testing other wire-free and radiation-free devices as it had proven to deliver superior results and benefits for the patient, the radiologist, and the surgeon.”

“Like ourselves, the team at The Christ Hospital Health Network is dedicated to reimagining what healthcare can be and truly understanding patient-first care,” said Fazila Seker, Ph.D., President and CEO of MOLLI Surgical Inc. “We are committed to helping them create more efficiencies in their radiology and surgery departments and deliver exceptional outcomes and experiences for their patients.”

MOLLI Surgical’s FDA-cleared MOLLI® allows surgeons to pinpoint cancerous tissue for faster, more accurate, and less painful tumor removal, offering an improved experience and better cosmetic outcomes for breast cancer patients, as well as patients living with different types of cancers. The wire-free technology includes the MOLLI Marker®, about the size of a sesame seed, that can be detected using the MOLLI Wand® and the MOLLI Tablet®.

To learn more about MOLLI Surgical, please visit: mollisurgical.com.

About The Christ Hospital Health Network:

The Christ Hospital Health Network is an acute care hospital located in Mt. Auburn with a remote hospital location in Liberty Township, five ambulatory outpatient centers, and dozens of offices conveniently located throughout the region. More than 1,300 talented physicians and more than 6,000 dedicated team members support the Network. Its mission is to improve the health of the community and to create patient value by providing exceptional outcomes and the finest experiences, all in an affordable way. The Network has been recognized by U.S. News & World Report as the #1 hospital in the Cincinnati region and awarded Healthgrades “America’s 50 Best Hospitals” for being in the top 1% in the nation for providing the highest clinical quality year over year. It is also a Press Ganey Guardian of Excellence Award recipient, which recognizes top-performing healthcare organizations that achieve the 95th percentile or above of performance in patient experience. The Christ Hospital is among a select number of hospitals in the nation to be awarded Magnet® recognition for nursing excellence. For more than 130 years, The Christ Hospital has provided compassionate care to those it serves.

About MOLLI Surgical:

MOLLI Surgical started in the operating room, where surgeons were using dated tools to treat cancer patients — and we knew we could do better. Our surgical wand is precise, easy-to-use, and built with the realities of the operating room in mind. More importantly, it is built with patients in mind. Our technology replaces procedures to mark tumors with one that is not only kinder — but more accurate, efficient, and cost-effective. MOLLI Surgical is proud to build the advanced equipment that patients prefer to have and that physicians prefer to use. Follow us on Facebook, LinkedIn, Twitter, and YouTube.

Share article on social media or email:



Increasing Clinical Trial Diversity — Innovations to Overcome Barriers to Trial Participation, Upcoming Symposium Hosted by Xtalks


Join this symposium to discuss varied topics regarding patient advocacy, sites and sponsors and explore approaches and considerations to increase clinical trial diversity.

Ensuring appropriate diverse demographic representation in clinical trials is imperative for all involved in bringing the miracle of new medicines to market — sponsors, CROs, sites, physicians and above all, the patients that are at the heart of any successful trial. Clinical trial diversity should be a key consideration when recruiting trial participants.

This symposium will review some of the critical thinking and innovative solutions that Labcorp is implementing to overcome barriers to participation. As a leading global CRO, Labcorp has designed a “Patient Recruitment Ecosystem” that embeds diversity and inclusion into clinical trials through powerful data driven insights, patient and site informed study feasibility and design, site enablement and support, innovative patient engagement and recruitment techniques and study diversity monitoring and reporting.

Join this symposium to discuss varied topics regarding patient advocacy, sites and sponsors and explore approaches and considerations to increase clinical trial diversity.

Join Maimah Karmo, President & Founder, Tigerlily Foundation; Monica Eason, Clinical Operations Portfolio Leader, Roche; Dr. Irfan Khan, Founder & CEO, Circuit Clinical; Dr. Kashyap Patel, MD, CEO, Carolina Blood and Cancer Care Associates; Michelle LaBruyere, Head of Operational Delivery, Enterprise Wide Business Unit; Dr. Oren Cohen, MD, President, Clinical Pharmacology Services and Chief Medical Officer, Labcorp Drug Development; and Elizabeth George, Senior Director, Diversity & Inclusion, Site and Patient Engagement, Labcorp Drug Development, for the live symposium on Thursday, September 08, 2022, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Increasing Clinical Trial Diversity — Innovations to Overcome Barriers to Trial Participation.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Dr Hen Says Creates Informative Health Education Cartoon about Body-Focused Repetitive Behaviors with The TLC Foundation


News Image

“I want to normalize the reality of living with a medical condition and encourage more open conversations,” said Dr Hen.

The TLC Foundation for Body-Focused Repetitive Behaviors (BFRBs) is proud to announce a partnership with Dr Hen Says to bring greater awareness and understanding to body-focused repetitive behaviors through a health education cartoon.

Launching this morning through Instagram and Facebook, the latest Dr Hen Says health education cartoon features a series of illustrations focused on dispelling myths and misperceptions about common, but rarely discussed body-focused repetitive behaviors like hair pulling, skin picking, nail biting, cheek biting, along with hair ingestion, and skin eating.

The TLC Foundation for Body-Focused Repetitive Behaviors brings awareness and support to this underreported and misunderstood group of mental health disorders that impacts approximately one in 20 Americans. Body-Focused Repetitive Behaviors are complex medical diagnoses that affect children and adults alike, and often cause shame, isolation, and emotional distress. Yet despite their prevalence, these behaviors are rarely discussed in the general public.

For many, BFRBs are self-regulating and serve some internal need. BFRBs are not self-harm or self-mutilation. BFRBs are not caused by trauma or bad parenting. When a person engages in their BFRB, physical damage is created as an unintentional result of their behavior, not as a self-harming mechanism.

“The TLC Foundation for Body-Focused Repetitive Behaviors is grateful to Dr Hen Says for their willingness to share factual information about hair pulling, skin picking, nail biting, cheek biting and other associated behaviors to grow awareness and understanding,” commented Jen Monteleone, Interim Executive Director of the TLC Foundation for Body-Focused Repetitive Behaviors.

Dr Hen Says shares topics that are of health concern for audiences that can be difficult to discuss. The Dr Hen Says website and social platforms help to ease difficult conversations by raising awareness, debunking common misconceptions, and breaking through negativity with compassion, inclusiveness, and decency. By sharing information in a simple and non-intimidating manner, Dr Hen Says works to help individuals make better health decisions with a supportive community around health topics.

“I want to normalize the reality of living with a medical condition and encourage more open conversations,” said Dr Hen. “No topic should be taboo, and no one should have to feel ashamed about their health challenge. Sharing credible medical information can help many; the more knowledge you have, the healthier you can be.”

View all the Body-Focused Repetitive Behaviors (BFRBs) Dr Hen Says Images:https://drive.google.com/drive/folders/1K4GXZYt1jkxm8r3kH57m1JkbjGKzebPy?usp=sharing

About the TLC Foundation for Body-Focused Repetitive Behaviors

The TLC Foundation for Body-Focused Repetitive Behaviors is a 501(c)3 health-related human services organization dedicated to supporting the 1-in-20 individuals experiencing body-focused repetitive behaviors (BFRBs) through advocacy, awareness, connection, health education, celebration, and equitable access to effective evidence-based treatments. To learn more, visit http://www.bfrb.org.

To learn more about hair pulling and other body-focused repetitive behaviors, download TLC’s Expert Consensus Treatment Guidelines: https://www.bfrb.org/storage/documents/Expert_Consensus_Treatment_Guidelines_2016w.pdf

About Dr Hen Says

Dr Hen Says shares animation and illustrations on social media to raise awareness, fight stigmas, and build communities around health topics – using simple language, relatable characters, and a dose of light-hearted humor. Dr Hen Says works closely with many international foundations and universities. To learn more, visit http://www.Hen.World.

###

Body-Focused Repetitive Behaviors

Subject Matter Experts for Media Interviews

The TLC Foundation offers the following subject matter experts for media interviews.

To schedule an interview, please contact:

Jen Monteleone, Interim Executive Director

E: jmonteleone@bfrb.org

P: 831-457-1004 ext. 1

Research:

  • Dr. John Piacentini, TLC Board President & TLC Scientific Advisory Board Chair, UCLA
  • Dr. Nancy Keuthen, Massachusetts General Hospital/Harvard Medical School
  • Dr. Jon Grant, University of Chicago
  • Dr. Darin Dougherty, Massachusetts General Hospital/Harvard Medical School
  • Dr. Doug Woods, Marquette University
  • Dr. Marty Franklin, University of Pennsylvania School of Medicine
  • Dr. Tara Perris, UCLA
  • Dr. Emily Ricketts, UCLA

Medicine:

  • Dr. Jon Grant, University of Chicago
  • Dr. Darin Dougherty, Massachusetts General Hospital/Harvard Medical School

Treatment:

  • Dr. John Piacentini, TLC Board President & TLC Scientific Advisory Board Chair, UCLA
  • Dr. Suzanne Mouton-Odum, TLC Board Vice President & TLC Scientific Advisory Board Vice Chair, Psychology Houston, PC
  • Dr. Nancy Keuthen, Massachusetts General Hospital/Harvard Medical School
  • Dr. Charles Mansueto, Behavior Therapy Center of Greater Washington
  • Dr. Fred Penzel, TLC Board Vice Secretary & TLC Scientific Advisory Board Secretary, Western Suffolk Psychological Services
  • Ruth Golomb, Behavior Therapy Center of Greater Washington
  • Dr. Doug Woods, Marquette University
  • Dr. Marty Franklin, University of Pennsylvania School of Medicine
  • Dr. Tara Perris, UCLA
  • Dr. Emily Ricketts, UCLA

Share article on social media or email: